A 12-month prospective study to evaluate the efficacy of using the treat-and-extend regimen with intravitreal aflibercept as a Second-Line Treatment for Diabetic Macular Oedema (the TADI Study)
- Liran Tiosano
- , Rita Ehrlich
- , Yoreh Barak
- , Haya Katz
- , Russell Pokroy
- , Tarek Jaouni
- , Jaime Levy
- , Joel Hanhart
- , Ori Segal
- , Shiri Shulman
- , Michaella Goldstein
- , Itay Chowers
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations